Periodontal Status and Disease Severity in Hidradenitis Suppurativa Patients

Evaluation of Periodontal Status in Individuals With Hidradenitis Suppurativa: A Cross-Sectional Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07294456

Enrollment

226

Registered

2025-12-19

Start date

2025-06-01

Completion date

2025-09-15

Last updated

2025-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HİDRADENİTİS SUPPURATİVA

Keywords

HİDRADENİTİS SUPPURATİVA, PERİODONTAL DİSEASE, PERİODONTİTİS, GİNGİVAL İNFLAMMATİON

Brief summary

This cross-sectional study aims to evaluate the periodontal status of individuals diagnosed with hidradenitis suppurativa (HS) and to compare them with systemically healthy controls. HS is a chronic inflammatory skin disease characterized by recurrent lesions and systemic inflammation, which may influence periodontal health. In this study, periodontal parameters-including probing depth, clinical attachment loss, gingival index, plaque index, and bleeding on probing-will be assessed using standard clinical methods. Dermatological examination will include disease duration, lesion characteristics, and Hurley staging. The study will investigate the prevalence of periodontitis in HS patients and explore potential associations between periodontal findings and HS severity. Findings from this research may provide insight into shared inflammatory pathways and contribute to understanding the possible link between HS and periodontal disease.

Interventions

OTHERNo intervention (observational study)

Observational study with no treatment or intervention applied.

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Minutes to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Having a diagnosis of hidradenitis suppurativa. * Age greater than 18 years. * Presence of at least 12 teeth in the mouth, excluding third molars.

Exclusion criteria

* Age under 18 years. * Pregnancy. * Breastfeeding. * Receiving treatment for periodontitis or hidradenitis suppurativa within the past 3 months. * Use of antibiotics, anti-inflammatory drugs, or immunomodulatory medications within the past 3 months.

Design outcomes

Primary

Measure	Time frame
Correlation Between Periodontal Status and Hidradenitis suppurativa	Baseline (single assessment)

Secondary

Measure	Time frame
Corralation between Hurley Stage and Oral Health Impact Profile OHIP-14) Score	baseline (single assesment)
Correlation between Periodontal Status and Hurley Stage	Baeline (single assesment)
Correlation between Dermatology Life Quality Index (DLQI) and Oral Health Impact Profile (OHIP-14) Total Score	baseline (single assesment)

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026